This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Exercise Training in Patients With Non-cystic Fibrosis (CF) Bronchiectasis

This study has been completed.
Austin Health
Sir Charles Gairdner Hospital
Curtin University
Information provided by (Responsible Party):
Bayside Health Identifier:
First received: April 21, 2009
Last updated: March 10, 2014
Last verified: March 2014

The aim of this project is to examine the short and long term effects of an 8 week, twice weekly, outpatient exercise training program for people with bronchiectasis. Participants will be randomly allocated to undergo a supervised exercise training program at The Alfred, Austin Hospital or Sir Charles Gairdner Hospital.

The hypotheses of this study are:

  1. Patients with bronchiectasis who complete an exercise program will have a higher exercise capacity and better quality of life and these improvements will be sustained for up to 12 months after completion
  2. Exercise training will significantly reduce the incidence of pulmonary exacerbations, use of antibiotics and rate of hospitalisation

Condition Intervention Phase
Bronchiectasis Other: Exercise Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Exercise Training in Patients With Non-CF Bronchiectasis - a Multi-centre Randomized Controlled Trial

Resource links provided by NLM:

Further study details as provided by Bayside Health:

Primary Outcome Measures:
  • Incremental Shuttle Walk Test Chronic Respiratory Disease questionnaire [ Time Frame: July 2011 ]

Secondary Outcome Measures:
  • 6-Minute Walk Test [ Time Frame: July 2011 ]

Enrollment: 39
Study Start Date: February 2009
Study Completion Date: February 2013
Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Exercise
8 week, twice weekly exercise program with both endurance and upper and lower limb strength training
Other: Exercise
8 week, twice weekly exercise program with endurance and upper and lower limb strength training
No Intervention: 2
No exercise, twice weekly phone calls

Detailed Description:

Bronchiectasis not related to cystic fibrosis (non-CF bronchiectasis) is a chronic respiratory condition characterised by permanent dilatation of the airways arising from bronchial inflammation and infection. Predominant symptoms include daily productive cough, dyspnoea and generalised fatigue. This profile is associated with diminished health-related quality of life (HRQOL) and reduced exercise tolerance.

Available medical treatments for bronchiectasis include antibiotic and inhalation therapy. To date, there is no evidence that these treatments can reduce the exacerbation rate or modify the rate of disease progression. While international guidelines for pulmonary rehabilitation recommend the inclusion of patients with bronchiectasis, there is a deficiency in evidence supporting exercise training in this population. It is proposed that a standard exercise training program conducted according to Australian guidelines for pulmonary rehabilitation will improve both exercise capacity, quality of life and reduce the number of acute infections in both the short and long term in people with bronchiectasis.


Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Diagnosis of bronchiectasis (HRCT)
  • Stable medical status for last 4 weeks
  • History of 2 exacerbations in the last 2 years
  • Dysnpoea on exertion (Modified Medical Research Council score >1)

Exclusion Criteria:

  • Concurrent diagnosis of COPD (physician diagnosis and history of 10 pack year smoking)
  • Concurrent diagnosis of asthma (history of atopic disease and evidence of bronchodilator reversibility of 12% or 200ml in FEV1 or FVC)
  • Concurrent diagnosis of Interstitial lung disease
  • Concurrent diagnosis of Cystic Fibrosis
  • Medical condition which could place patient at risk during exercise training (angina, neurological or orthopaedic condition)
  • Prior completion of pulmonary rehabilitation within the last 12 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00885521

Australia, Victoria
The Alfred
Melbourne, Victoria, Australia, 3004
Austin Health
Melbourne, Victoria, Australia
Australia, Western Australia
Sir Charles Gairdner Hospital
Perth, Western Australia, Australia
Sponsors and Collaborators
Bayside Health
Austin Health
Sir Charles Gairdner Hospital
Curtin University
Principal Investigator: Annemarie L Lee, PhD Bayside Health